Streamcheck
Streamcheck is a German health-tech company selling a patented, CE-certified home uroflowmetry device and app that let men 45+ monitor bladder, kidney, and prostate health, while supplying long-term data to urologists, GPs, and pharmacies.
- Company typePrivate
- Founded2023
- HeadquartersVierkirchen, Germany
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Streamcheck does
Streamcheck (legal entity Streamcheck GmbH) is a German health-technology company founded in 2023 and headquartered in Vierkirchen, Germany, that develops a home-based urological early-detection system. The product enables men — particularly those aged 45+ concerned about prostate health, benign prostatic hyperplasia (BPH), and bladder/kidney conditions — to perform uroflowmetry (urine flow rate, volume, and duration) and biochemical biomarker analysis (e.g., sugar and protein content via integrated test strips) at home, without a clinic visit. The company also serves healthcare professionals — urologists, general practitioners, and pharmacies — through a dedicated "Fachkreis" (professional circle) portal that supplies long-term uroflow and biomarker data to support patient care.
The core offering combines a patent-pending, CE-certified measuring device (regulated as a medical device under EU MDR 2017/745, "Made in Germany") with a companion smartphone app connected via Bluetooth. Measurement data is transmitted to the app for detailed analysis and trend visualization (including Qmax, Qavg, and micturition volume), and processed on AWS cloud infrastructure hosted in EU data centers (Frankfurt). Additional product surfaces include a free IPSS-based (International Prostate Symptom Score) self-test questionnaire used for screening and lead generation, and a medical report feature for professional review. The technology stack integrates Stripe for payments, Silver ERP for order processing, and Google Firebase for app analytics and notifications.
The business model centers on direct-to-consumer hardware sales of the "All-in-One" device package (one-time purchase) sold through its own e-commerce storefront (streamcheck.io/shop), complemented by recurring test-strip consumables revenue. Go-to-market is product-led and D2C via self-serve online ordering, amplified by content marketing, organic social media, PR/earned media (including an appearance on the German TV show "Die Höhle der Löwen"), plus a B2B field/recommendation motion through healthcare professionals. Clinical credibility is reinforced by academic partnerships with Saarland University, Leipzig University Hospital, University Medical Center Freiburg, and St. Antonius Hospital Gronau, alongside a relationship with statutory health insurer BKK Pfalz. Specific pricing and revenue figures are not publicly disclosed.
Streamcheck firmographics
Firmographics- Name
- Streamcheck
- Legal name
- Streamcheck GmbH
- Website
- https://streamcheck.io
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Streamcheck is a German health-tech company selling a patented, CE-certified home uroflowmetry device and app that let men 45+ monitor bladder, kidney, and prostate health, while supplying long-term data to urologists, GPs, and pharmacies.
- Ownership category
- akta.pro rank
Streamcheck industry classification
Industry- Product category
- Home Uroflowmetry Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Urinalysis & Routine Screening Diagnostics (HLAHAAAG)
- akta.pro secondary industry
- Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ)
Keywords
Where Streamcheck is headquartered
LocationHeadquarters
- HQ city
- Vierkirchen
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Streamcheck business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Infrastructure
Revenue model
- Hardware Device Sales: Sale of the Streamcheck measuring device (Uroflowmeter) as the primary product. The device is sold as an 'All-in-One' package and is described as patented, certified, and approved as a medical device (CE-marked).
- Test Strip Consumables: Recurring consumables revenue from test strip refills used with the measuring device for biomarker analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Streamcheck All-in-One Package |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
Streamcheck product offering
Product offeringCore offering
Streamcheck develops and sells a patented, CE-certified medical device for home-based uroflowmetry that measures urine flow rate, volume, and duration, combined with integrated biochemical test strips for biomarker analysis (sugar, protein). Measurement data is transmitted via Bluetooth to a companion smartphone app for trend visualization and is supported by a free IPSS-based self-test and a professional portal for healthcare providers.
Product overview
Streamcheck is a German-developed urological screening system consisting of a patented measuring device with integrated test strips for home uroflowmetry and biomarker analysis, a companion mobile app for data visualization and trend tracking, a free IPSS-based self-test questionnaire, and a professional portal for doctors. The product portfolio centers on enabling discreet at-home monitoring of bladder and kidney health, with data optionally shared with healthcare providers.
Differentiator
Problem solved
Functional benefit
Products and services
- Streamcheck All-in-One Device A patented, CE-certified medical device for home uroflowmetry that captures urine flow rate, volume, and duration through integrated sensors and combines this with biochemical test strip analysis for biomarkers such as sugar and protein. Sold as a complete package with initial test strips, marketed primarily to men aged 45+ for self-monitoring of bladder and kidney health.
- Streamcheck Test Strip Refills Recurring consumable test strips used with the Streamcheck measuring device to perform biochemical analysis of urine biomarkers, generating ongoing consumables revenue for repeat measurements.
- Selbsttest (IPSS Self-Assessment) A free online self-assessment based on the International Prostate Symptom Score (IPSS) questionnaire consisting of seven questions that evaluate symptoms such as frequent urination and urination problems, providing an initial screening that supports early prostate health awareness.
- Fachbericht (Medical Report) A professionally reviewed medical report service that interprets Streamcheck uroflowmetry and biomarker results, intended to support consultation with healthcare providers.
Companies that use Streamcheck
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Streamcheck technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature5 records
Streamcheck partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Universität des Saarlandes (Saarland University)coreAcademic partnership with Saarland University for scientific research in urological health and uroflowmetry methodology. The partnership involves academic collaboration and methodological development for the Streamcheck measuring technology. University logo appears prominently on the website footer indicating significant co-development relationship.
- Universitätsklinikum Leipzig (Leipzig University Hospital)coreClinical research partnership with Leipzig University Hospital for scientific research and clinical validation of urological health monitoring. University logo displayed on website indicating active collaboration in health research and product development.
- Universitätsklinikum Freiburg (University Medical Center Freiburg)coreAcademic partnership with University Medical Center Freiburg for scientific research in urological health. Partnership contributes to clinical credibility and research validation of Streamcheck's home monitoring solutions.
- St. Antonius Hospital GronaucoreClinical partnership with St. Antonius Hospital Gronau for scientific research and clinical validation. Hospital logo appears on website footer indicating collaborative relationship in urological health research.
- BKK PfalzminorPartnership with German statutory health insurance provider BKK Pfalz. Logo displayed on website footer indicating collaboration in health insurance coverage or reimbursement discussions for Streamcheck products.
- Amazon Web Services (AWS)coreAWS hosts Streamcheck's app and entire technical infrastructure. Data processing and storage occurs exclusively in EU data centers (EU Central, Frankfurt). AWS services used include Cognito, Lambda, RDS (MySQL), CloudFront, ElasticBeanstalk, Simple Email Service, Amplify, S3, EC2, CloudWatch.
- StripecoreStripe handles secure payment processing for customer purchases through Streamcheck's e-commerce platform. Data sharing includes name, address, and email for order fulfillment.
Scale indicators4 records
Recent moves5 records
Expansion highlights7 records
Streamcheck competitors and assessment
Company assessmentEmerging players
- Withings: Withings is a consumer health hardware company selling connected scales, blood pressure monitors, sleep mats, and home urinalysis devices via DTC e-commerce. It shares the DTC, app-connected home health hardware model and consumer urology overlap (their U-Scan device analyzes urine in the toilet).
- Hims & Hers Health: Hims & Hers is a direct-to-consumer men's health and wellness platform addressing stigmatized conditions (hair loss, ED, etc.) via telemedicine and online prescribing. It demonstrates the consumer willingness to address taboo male health issues online that Streamcheck is also targeting, though via a device-plus-DTC model.
- Ro (Roman): Ro's Roman brand is a direct-to-consumer men's health platform (ED, hair loss, testosterone, fertility) that pioneered DTC tele-urology. It represents the consumer behavior pattern Streamcheck depends on — men paying out-of-pocket for at-home management of sensitive urological issues.
- Everlywell: Everlywell is a US-based direct-to-consumer home diagnostics company selling mail-in test kits across a broad range of biomarkers. It represents the at-home consumer health diagnostics distribution model and the recurring consumables economics that Streamcheck is replicating in urology.
Direct peers
- Verathon: Verathon manufactures the BladderScan, a bladder-volume ultrasound device used in urology. It is the most direct clinical analogue to Streamcheck in the urological point-of-care diagnostics space, though Verathon's product is clinician-facing rather than consumer home-use.
- Mediwise (iUFlow): Mediwise makes the iUFlow home uroflowmetry device — the closest direct competitor to Streamcheck, measuring urine flow at home with an app-connected device. Both target the same patient population and use case, making it the most direct head-to-head in the home uroflowmetry category.
- Laborie Medical Technologies: Laborie is a global leader in urology diagnostics and urodynamics equipment, including uroflowmetry devices used in clinical practice. It is the dominant incumbent in the uroflowmetry category that Streamcheck is now extending into the home setting.
Regional players
- Numan: Numan is a UK-based DTC men's health and telehealth platform covering ED, hair loss, and urological conditions with a direct-to-consumer subscription model. It is a regional analogue of Hims/Roman and represents the same category Streamcheck is selling into, focused on the UK market.
Broad incumbents
- Storz Medical: Storz Medical is an established medical device manufacturer with a portfolio including uroflowmetry systems used in urology clinics. It is a clinical incumbent in uroflowmetry and represents the established competitor Streamcheck would need to displace as it pushes the same measurement into the home.
- Abbott (Lingo, FreeStyle Libre): Abbott is a global medical device incumbent operating consumer-facing continuous health monitoring brands (Lingo, FreeStyle Libre) and broad IVD diagnostics. It represents the strategic incumbent most likely to enter home urology monitoring if Streamcheck proves the category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Streamcheck social profiles
Digital presenceStreamcheck compliance and trust
Trust signalCompliance3 records
Streamcheck financial estimates
Financial estimateRevenue estimate
Valuation estimate
Streamcheck leadership team
Management profileNumber of profiles
Streamcheck funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Streamcheck M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Streamcheck
What does Streamcheck do?
Streamcheck develops and sells a patented, CE-certified medical device for home-based uroflowmetry that measures urine flow rate, volume, and duration, combined with integrated biochemical test strips for biomarker analysis (sugar, protein). Measurement data is transmitted via Bluetooth to a companion smartphone app for trend visualization and is supported by a free IPSS-based self-test and a professional portal for healthcare providers.
Is Streamcheck a public or private company?
Streamcheck is a private company. It is classified as unknown and is currently operating.
When was Streamcheck founded?
Streamcheck was founded in 2023. It employs 1 to 10 people.
Where is Streamcheck based?
Streamcheck is headquartered in Vierkirchen, Germany, in the Europe region.
How does Streamcheck make money?
Two revenue lines are on record. Hardware Device Sales are the primary driver. The others are test Strip Consumables.
Who are Streamcheck's main competitors?
Emerging players on record are Withings, Hims & Hers Health, Ro (Roman) and Everlywell. Direct peers are Verathon, Mediwise (iUFlow) and Laborie Medical Technologies. Numan is listed as a regional player. Broad incumbents are Storz Medical and Abbott (Lingo, FreeStyle Libre).
Does Streamcheck have an API?
No public API is recorded for Streamcheck.
What industry is Streamcheck in?
Streamcheck's product category is Home Uroflowmetry Medical Devices. Its primary akta.pro industry code is HLAHAAAG, Urinalysis & Routine Screening Diagnostics, with a secondary code of HLAHAKAJ, Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status). Its NAICS code is 334510 and its SIC code is 2835.